Literature DB >> 35583144

Defining optimal antithrombotic therapy post-TAVI: the contribution of ATLANTIS.

Felicita Andreotti1, Massimo Massetti1, Jurrien Ten Berg2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35583144     DOI： 10.1093/eurheartj/ehac139

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   35.855


× No keyword cloud information.
  1 in total

1.  Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient.

Authors:  Giuseppe Tarantini; Francesco Cardaioli
Journal:  Catheter Cardiovasc Interv       Date:  2022-08       Impact factor: 2.585
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.